EntryPoint Capital’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205K | Buy |
38,634
+8,480
| +28% | +$45K | 0.1% | 476 |
|
|
2025
Q1 | $267K | Sell |
30,154
-19,732
| -40% | -$175K | 0.12% | 392 |
|
|
2024
Q4 | $684K | Buy |
+49,886
| New | +$684K | 0.29% | 31 |
|
|
2024
Q1 | – | Sell |
-2,819
| Closed | -$54K | – | 1639 |
|
|
2023
Q4 | $54K | Buy |
+2,819
| New | +$54K | 0.05% | 679 |
|